Free Trial

FitLife Brands (FTLF) Competitors

FitLife Brands logo
$12.10 -0.51 (-4.04%)
Closing price 03/31/2025 04:00 PM Eastern
Extended Trading
$11.58 -0.53 (-4.34%)
As of 03/31/2025 04:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FTLF vs. RLAY, CGEM, MNMD, PGEN, PHAT, KROS, AUTL, VERV, ZVRA, and CRMD

Should you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include Relay Therapeutics (RLAY), Cullinan Therapeutics (CGEM), Mind Medicine (MindMed) (MNMD), Precigen (PGEN), Phathom Pharmaceuticals (PHAT), Keros Therapeutics (KROS), Autolus Therapeutics (AUTL), Verve Therapeutics (VERV), Zevra Therapeutics (ZVRA), and CorMedix (CRMD). These companies are all part of the "pharmaceutical products" industry.

FitLife Brands vs.

Relay Therapeutics (NASDAQ:RLAY) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, community ranking, profitability, risk and earnings.

FitLife Brands has higher revenue and earnings than Relay Therapeutics. Relay Therapeutics is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Relay Therapeutics$10.01M44.38-$341.97M-$2.39-1.10
FitLife Brands$62.76M1.78$5.30M$0.8414.40

Relay Therapeutics has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500.

In the previous week, FitLife Brands had 5 more articles in the media than Relay Therapeutics. MarketBeat recorded 16 mentions for FitLife Brands and 11 mentions for Relay Therapeutics. Relay Therapeutics' average media sentiment score of 0.55 beat FitLife Brands' score of 0.28 indicating that Relay Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Relay Therapeutics
3 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
FitLife Brands
3 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Relay Therapeutics currently has a consensus price target of $19.80, suggesting a potential upside of 655.73%. FitLife Brands has a consensus price target of $20.50, suggesting a potential upside of 69.42%. Given Relay Therapeutics' higher probable upside, equities research analysts clearly believe Relay Therapeutics is more favorable than FitLife Brands.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Relay Therapeutics
0 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.90
FitLife Brands
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

FitLife Brands has a net margin of 13.38% compared to Relay Therapeutics' net margin of 0.00%. FitLife Brands' return on equity of 28.03% beat Relay Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Relay TherapeuticsN/A -45.75% -40.75%
FitLife Brands 13.38%28.03%15.13%

Relay Therapeutics received 59 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 70.45% of users gave Relay Therapeutics an outperform vote while only 60.00% of users gave FitLife Brands an outperform vote.

CompanyUnderperformOutperform
Relay TherapeuticsOutperform Votes
62
70.45%
Underperform Votes
26
29.55%
FitLife BrandsOutperform Votes
3
60.00%
Underperform Votes
2
40.00%

97.0% of Relay Therapeutics shares are owned by institutional investors. Comparatively, 2.3% of FitLife Brands shares are owned by institutional investors. 4.3% of Relay Therapeutics shares are owned by insiders. Comparatively, 61.3% of FitLife Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

FitLife Brands beats Relay Therapeutics on 11 of the 19 factors compared between the two stocks.

Remove Ads
Get FitLife Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FTLF vs. The Competition

MetricFitLife BrandsMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$111.44M$1.14B$5.63B$7.79B
Dividend YieldN/AN/A5.37%4.04%
P/E Ratio14.329.3123.6118.68
Price / Sales1.785.66373.3989.80
Price / Cash19.0510.4038.1734.64
Price / Book3.981.176.734.12
Net Income$5.30M-$54.34M$3.20B$247.10M
7 Day Performance-9.36%-5.80%-5.33%-3.82%
1 Month Performance-19.39%-16.94%-0.40%-6.61%
1 Year Performance-1.22%-41.86%7.89%-1.67%

FitLife Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FTLF
FitLife Brands
4.4964 of 5 stars
$12.10
-4.0%
$20.50
+69.4%
+1.6%$111.44M$62.76M14.3220Earnings Report
Short Interest ↓
Analyst Revision
High Trading Volume
RLAY
Relay Therapeutics
2.1904 of 5 stars
$2.62
-3.7%
$19.80
+655.7%
-68.4%$444.15M$10.01M-1.00330News Coverage
CGEM
Cullinan Therapeutics
2.1256 of 5 stars
$7.57
-5.6%
$32.86
+334.0%
-55.6%$442.94MN/A-2.6730Positive News
MNMD
Mind Medicine (MindMed)
2.1861 of 5 stars
$5.85
-5.5%
$25.11
+329.2%
-37.8%$440.90MN/A-2.5940Gap Down
PGEN
Precigen
3.5645 of 5 stars
$1.49
-6.3%
$7.00
+369.8%
+2.8%$438.12M$3.93M-2.71190Gap Up
PHAT
Phathom Pharmaceuticals
3.2905 of 5 stars
$6.27
-5.0%
$22.17
+253.5%
-41.0%$436.62M$55.25M-1.10110
KROS
Keros Therapeutics
3.5098 of 5 stars
$10.19
-5.6%
$42.33
+315.4%
-84.6%$413.33M$3.55M-1.96100News Coverage
Gap Down
High Trading Volume
AUTL
Autolus Therapeutics
3.0281 of 5 stars
$1.55
-6.6%
$9.52
+514.2%
-75.7%$412.45M$10.12M-1.28330Positive News
Gap Down
VERV
Verve Therapeutics
1.7945 of 5 stars
$4.57
-12.5%
$25.50
+458.0%
-65.6%$405.80M$32.33M-1.86110Gap Down
ZVRA
Zevra Therapeutics
2.9815 of 5 stars
$7.49
-4.6%
$22.29
+197.5%
+29.1%$405.33M$23.61M-3.8020Positive News
CRMD
CorMedix
2.6034 of 5 stars
$6.16
-8.6%
$15.14
+145.8%
+45.3%$401.52M$43.47M-7.6030Earnings Report
Gap Down
High Trading Volume
Remove Ads

Related Companies and Tools


This page (NASDAQ:FTLF) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners